Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?

Gianfranco Ferraccioli; Stefano Alivernini; Barbara Tolusso; Elisa Gremese

doi:10.1016/j.autrev.2018.01.013

Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?

Gianfranco Ferraccioli, Stefano Alivernini, Barbara Tolusso, Elisa Gremese

Risultato della ricerca: Contributo in rivista › Articolo in rivista

4 Citazioni (Scopus)

Abstract

N/A

Lingua originale	English
pagine (da-a)	636-638
Numero di pagine	3
Rivista	Autoimmunity Reviews
Volume	17
DOI	https://doi.org/10.1016/j.autrev.2018.01.013
Stato di pubblicazione	Pubblicato - 2018

Keywords

Antinuclear antibodies
Cardiovascular disease
Immunology
Immunology and Allergy
Interstitial lung disease
Mortality
Peripheral venous thrombosis
Rheumatoid factor

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.autrev.2018.01.013

Altri file e collegamenti

Fingerprint

Entra nei temi di ricerca di 'Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?'. Insieme formano una fingerprint unica.

Cita questo

Ferraccioli, G., Alivernini, S., Tolusso, B., & Gremese, E. (2018). Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? Autoimmunity Reviews, 17, 636-638. https://doi.org/10.1016/j.autrev.2018.01.013

Ferraccioli, Gianfranco ; Alivernini, Stefano ; Tolusso, Barbara et al. / Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?. In: Autoimmunity Reviews. 2018 ; Vol. 17. pagg. 636-638.

@article{7a1fd0e9c5114c969928cab7c52d6a3f,

title = "Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?",

abstract = "N/A",

keywords = "Antinuclear antibodies, Cardiovascular disease, Immunology, Immunology and Allergy, Interstitial lung disease, Mortality, Peripheral venous thrombosis, Rheumatoid factor, Antinuclear antibodies, Cardiovascular disease, Immunology, Immunology and Allergy, Interstitial lung disease, Mortality, Peripheral venous thrombosis, Rheumatoid factor",

author = "Gianfranco Ferraccioli and Stefano Alivernini and Barbara Tolusso and Elisa Gremese",

year = "2018",

doi = "10.1016/j.autrev.2018.01.013",

language = "English",

volume = "17",

pages = "636--638",

journal = "Autoimmunity Reviews",

issn = "1568-9972",

publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",

}

Ferraccioli, G, Alivernini, S, Tolusso, B & Gremese, E 2018, 'Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?', Autoimmunity Reviews, vol. 17, pagg. 636-638. https://doi.org/10.1016/j.autrev.2018.01.013

Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? / Ferraccioli, Gianfranco; Alivernini, Stefano; Tolusso, Barbara et al.
In: Autoimmunity Reviews, Vol. 17, 2018, pag. 636-638.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?

AU - Ferraccioli, Gianfranco

AU - Alivernini, Stefano

AU - Tolusso, Barbara

AU - Gremese, Elisa

PY - 2018

Y1 - 2018

N2 - N/A

AB - N/A

KW - Antinuclear antibodies

KW - Cardiovascular disease

KW - Immunology

KW - Immunology and Allergy

KW - Interstitial lung disease

KW - Mortality

KW - Peripheral venous thrombosis

KW - Rheumatoid factor

KW - Antinuclear antibodies

KW - Cardiovascular disease

KW - Immunology

KW - Immunology and Allergy

KW - Interstitial lung disease

KW - Mortality

KW - Peripheral venous thrombosis

KW - Rheumatoid factor

UR - http://hdl.handle.net/10807/122408

UR - http://www.elsevier.com/locate/autrev

U2 - 10.1016/j.autrev.2018.01.013

DO - 10.1016/j.autrev.2018.01.013

M3 - Article

SN - 1568-9972

VL - 17

SP - 636

EP - 638

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

ER -

Ferraccioli G, Alivernini S, Tolusso B, Gremese E. Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? Autoimmunity Reviews. 2018;17:636-638. doi: 10.1016/j.autrev.2018.01.013